TIA Patients' knowledge tested after ER visit – results may surprise

NCT ID NCT07040761

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how much people who had a transient ischemic attack (TIA or mini-stroke) understand about their condition after being treated in the emergency room. About 100 adults in Lyon, France, answered a questionnaire to test their knowledge of symptoms, risk factors, and what to do if symptoms return. The goal is to find gaps in understanding so doctors can better teach patients how to prevent a future stroke.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

100 people

The number who actually took part.

Started

Jun 2025

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients from the Lyon region who consulted an emergency department with a final diagnosis of TIA, and sent to the neurology day hospital of Pierre Wertheimer neurological hospital

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria : * Adult men and women ≥18 years old * Patient referred to neurology day hospital at the Pierre Wertheimer neurological hospital after first care in the emergency department * Patient having been informed and having expressed his non-opposition * Patient affiliate to a social security scheme Exclusion Criteria : * Patient unable to complete the questionnaire * History of stroke/TIA * Patient who do not understand the French language * Patient under legal protection, guardianship, curatorship, under judicial protection-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Transient ischemic attack are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Pierre Wertheimer hospital

    Bron, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.